Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Gains from Sales and Divestitures (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Gains from Sales and Divestitures for 14 consecutive years, with $457275.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 24.98% to $457275.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $457275.0, a 24.98% increase, with the full-year FY2025 number at $457275.0, up 24.98% from a year prior.
  • Gains from Sales and Divestitures was $457275.0 for Q4 2025 at Acadia Healthcare Company, up from $66676.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.4 million in Q1 2023 to a low of $66676.0 in Q1 2025.
  • A 5-year average of $414756.4 and a median of $359027.5 in 2021 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 2784.31% in 2021, then tumbled 86.35% in 2024.
  • Acadia Healthcare Company's Gains from Sales and Divestitures stood at $366048.0 in 2021, then surged by 41.64% to $518474.0 in 2022, then surged by 171.6% to $1.4 million in 2023, then crashed by 74.02% to $365871.0 in 2024, then grew by 24.98% to $457275.0 in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Gains from Sales and Divestitures are $457275.0 (Q4 2025), $66676.0 (Q3 2025), and $374741.0 (Q2 2025).